A Pilot Study of High-Dose Immunosuppression Followed by Infusion of CD34 Selected Autologous Peripheral Blood Stem Cells for Treatment of Severe Crohn's Disease in Children and Young Adults.

At a glance
Trial Overview
Trial Details
Interventions
Trial Centres
- Investigators
- Centres
Trial History
References

Trial Profile

A Pilot Study of High-Dose Immunosuppression Followed by Infusion of CD34 Selected Autologous Peripheral Blood Stem Cells for Treatment of Severe Crohn's Disease in Children and Young Adults.

Status: Recruiting

Phase of Trial: Phase I/II

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Immunosuppressants
Indications Crohn's disease
Focus Adverse reactions

Most Recent Events

05 Feb 2021 Biomarkers information updated
04 May 2012 Trial phase changed from I to I/II as reported by ClinicalTrials.gov.
06 Jan 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com